Aditya Bardia, MD, MPH, Attending Physician, Massachusetts General Hospital, Harvard Medical School, gives an overview of the Snapshot assay for breast cancer.
Aditya Bardia, MD, MPH, attending physician, Massachusetts General Hospital, Harvard Medical School, gives an overview of the Snapshot assay for breast cancer.
Snapshot looks at the 130 most common mutations by using multiplex PCR to amplify mutations in breast cancer. In the 4-year review presented at the 2013 Breast Cancer Symposium, the assay was ordered by physicians for patients with metastatic breast cancer.
Bardia says that more genotyping assays are being offered by various institutions, and that is important for community oncologists to understand cancer mutations. Snapshot is a particularly good assay because it only looks at actionable mutations.
PTCy Offers New Hope for Mismatched Stem Cell Transplants in Leukemia, MDS
April 13th 2024Jeff Auletta, MD, discussed how PTCy-based graft-vs-host disease prophylaxis offers a promising approach for expanding access to successful cell transplantation regardless of donor match or patient ethnicity.
Read More
UGT1A1 Status Underutilized in Predicting Sacituzumab Toxicity in MBC
April 8th 2024During a Case-Based Roundtable® event, Mark Pegram, MD, discussed the value of testing for UGT1A1 status in patients receiving sacituzumab govitecan for hormone receptor–positive breast cancer in the second article of a 2-part series.
Read More